Title: A Study on Treatment of Tennis Elbow by Platelet Rich Plasma

Authors: Dr Rahmat Ali, Dr Zafar Anis

 DOI: https://dx.doi.org/10.18535/jmscr/v9i11.36

Abstract

Background: In routine practice tennis elbow or lateral epicondylitis is commonly encountered enthesopathy, which disturbs the activity of daily life and it not only effects sports personnel but in our society major chunk of patients affected by it are house wife’s and manual workers, so an effective low-cost treatment modality is need of the hour. Autologous platelet-rich plasma (PRP) hastens the healing of angiofibroblastic degeneration in lateral epicondylitis by providing humoral modulators and array of different growth factors favours its use to treat enthesopathies.

Keywords: Lateral epicondylitis, Elbow, Platelet rich plasma (PRP).

References

  1. Ellenbecker TS, Nirschl R, Renstrom P. Current concepts in examination and treatment of elbow tendon injury. Sports Health 2013;5:186‐94.
  2. Solomon L, Warwick D, Nayagam S. Tennis Elbow (Lateral Epicondylitis) in Regional Orthopaedics, Apley’s System of Orthopaedics and Fractures. 9th ed. London: Published by CRC Press; 2010. p. 378-9.
  3. De Smedt T, de Jong A, Van Leemput W, Lieven D, Van Glabbeek F. Lateral epicondylitis in tennis: Update on aetiology, biomechanics and treatment. Br J Sports Med 2007;41:816-9.
  4. De La Mata J. Platelet rich plasma. A new treatment tool for the rheumatologist? Reumatol Clin 2013;9:166-71.
  5. Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: Current concepts and application in sports medicine. J Am Acad Orthop Surg 2009;17:602-8.
  6. de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 2008;36:1171-8.
  7. Anitua E, Andía I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-6.
  8. Kahlenberg CA, Knesek M, Terry MA. New developments in the use of biologics and other modalities in the management of lateral epicondylitis. Biomed Res Int 2015;2015:439309.
  9. Raeissadat SA, Sedighipour L, Rayegani SM, Bahrami MH, Bayat M, Rahimi R. Effect of platelet-rich plasma (PRP) versus autologous whole blood on pain and function improvement in tennis elbow: a randomized clinical trial. Pain Res Treat 2014;2014:191525.
  10. Verhaar JA, Walenkamp GH, van Mameren H, Kester AD, van der Linden AJ. Local corticosteroid injection versus cyriax-type physiotherapy for tennis elbow. J Bone Joint Surg Br 1996;78:128-32.
  11. Perez AG, Lana JF, Rodrigues AA, Luza AC, Belanera WD, Helena AM, et al. Relevant aspects of centrifugation step in the preparation of Platelet rich plasma. ISRN Hematol 2014;8:17060.
  12. Greene WB, editor. Essentials of Musculoskeletal Care. 2nd ed. Rosemont, IL: Published by the American Academy of Orthopaedic Surgeons; 2001.
  13. Haake M, König IR, Decker T, Riedel C, Buch M, Müller HH, et al. Extracorporeal shock wave therapy in the treatment of lateral Epicondylitis: A randomized multicenter trial. J Bone Joint Surg Am 2002;84-A:1982-91.
  14. Chesterton LS, Mallen CD, Hay EM. Management of tennis elbow. Open Access J Sports Med 2011;2:53-9.
  15. Yadav R, Kothari SY, Borah D. Comparison of local injection of platelet rich plasma and corticosteroids in the treatment of lateral epicondylitis of Humerus. J Clin Diagn Res 2015;9:RC05-7.

Corresponding Author

Dr Rahmat Ali (Ms (Ortho), MCh (Ortho) )

Professor and H.O.D (Ortho department), Maharishi Vashishtha Autonomous State Medical College, Basti, UP, India